Aramark Form 8-K Summary: Amendment No. 15 to Credit Agreement
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 2, 2024, discloses that Aramark (NYSE: ARMK) and its subsidiaries entered into Amendment No. 15 to their existing Credit Agreement. The filing details a significant refinancing and restructuring of the company's debt facilities, executed on the Closing Date of August 2, 2024.
Key Financial Metrics and Debt Structure
The Amendment establishes new borrowing facilities and refinances existing obligations. The filing does not provide revenue, profit, or cash flow metrics as this is a transactional filing rather than a periodic financial report. Key debt metrics include:
- New Revolving Commitments: $1.4 billion in 2024 Tranche Revolving Commitments, maturing in August 2029.
- Letters of Credit Sublimit: Increased to $500 million (an increase of $250 million from the prior facility).
- New Term Loans Funded:
- Canadian Term A-4 Loans: C$214,582,924.03
- Euro Term A-3 Loans: €94,055,554.21
- U.S. Term A Loans: $70,688,723.72
- U.S. Term A-1 Loans: $90,000,000.00
- GBP Term A Loans: £62,000,000.00
- Interest Margins: Initial margins range from 1.625% to 1.6576% depending on the currency and benchmark (SOFR, EURIBOR, SONIA, CORRA), with potential reductions based on leverage ratios.
- Commitment Fee: Initially set at 0.30% on unutilized revolving commitments.
Material Changes Versus Prior Period
The primary material change is the replacement of the 2021 Tranche Revolving Facility, Canadian Term A-3 Loans, and Euro Term A-2 Loans with new facilities extending maturity to August 2029. Specific changes include:
- Increased Liquidity Capacity: The letter of credit sublimit was raised by $250 million.
- Refinancing: New term loans were funded in full on the Closing Date to refinance specific outstanding loans and a portion of the revolving loans.
- Interest Rate Structure: The new facilities utilize updated benchmark rates (e.g., Term SOFR, Term CORRA, SONIA) with pricing grids tied to the company's consolidated leverage ratio.
Outlook, Risks, and Covenants
Management commentary is limited to the terms of the agreement. Key conditions and risks include:
- Leverage-Based Pricing: Interest margins and commitment fees are subject to reduction if the company achieves a consolidated leverage ratio of 4.75 to 1.00 or lower. Further reductions apply for every 0.50 decline in the ratio.
- Mandatory Maturity Acceleration: If the aggregate indebtedness under U.S. Term B-7 Loans and 5.00% Senior Notes due 2028 exceeds $500 million 91 days prior to their maturity, the new term loans may mature earlier than the scheduled August 2029 date.
- Covenants: The new facilities maintain substantially similar terms regarding guarantees, collateral, and mandatory prepayments as the prior agreement, with certain updates favorable to the Company.
Investor Verification Checklist
- Verify the exact amount of the 2021 Tranche Revolving Facility and Term Loans being refinanced to assess the net change in total debt load.
- Review the company's current consolidated leverage ratio to determine the applicable initial interest margin and commitment fee.
- Confirm the outstanding balance of U.S. Term B-7 Loans and 5.00% Senior Notes due 2028 to evaluate the risk of accelerated maturity for the new term loans.
- Examine the full text of Amendment No. 15 (Exhibit 10.1) for specific covenant definitions and "favorable updates" mentioned in the filing.